DW Healthcare Partners Acquires Majority Stake in CEFALY Technology SPRL
August 8, 2019
DW Healthcare Partners (DWHP) announced a majority investment in CEFALY Technology SPRL, a Liège, Belgium–based manufacturer of neuro‑modulating medical devices for prevention and treatment of migraines. The investment—DWHP’s first from its fifth fund—will support CEFALY’s next stage of global growth and coincides with the appointment of Jen Trainor as CEO to scale marketing, sales and distribution.
- Buyers
- DW Healthcare Partners
- Targets
- CEFALY Technology SPRL
- Industry
- Medical Devices
- Location
- Liège, Belgium
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Curewell Capital Majority Investment in Wilmington PharmaTech
October 21, 2025
Pharmaceuticals
Los Angeles-based private equity firm Curewell Capital has made a majority investment in Wilmington PharmaTech (WPT), a U.S.-based specialty CRDMO focused on small-molecule API development and manufacturing. Founder and CEO Hui-Yin "Harry" Li will retain a significant ownership stake and remain as CEO; the capital will be used to expand WPT's U.S. manufacturing capacity, including HPAPI suites, and scale end-to-end API development and manufacturing capabilities.
-
DW Healthcare Partners Invests in LKC Technologies
June 6, 2023
Medical Devices
DW Healthcare Partners, a healthcare-focused private equity firm, completed an investment in LKC Technologies, maker of the handheld RETeval electroretinography/visual evoked potential device. The transaction positions LKC to scale its diagnostic medical-device business globally under new CEO Dina Dubey as founder Jim Datovech transitions from the CEO role.
-
HCAP Partners and Baymark Partners Invest in DFW Neuropathy
September 27, 2022
Healthcare Services
Baymark Partners led an investment in DFW Neuropathy, a North Texas neuropathy treatment clinic, with HCAP Partners joining as an investor. The capital will support DFW Neuropathy’s expansion of its Combination Electroanalgesia Treatment (CET) services across the Dallas–Fort Worth metroplex.
-
CGE Partners Invests in Datapharm
February 28, 2022
Pharmaceuticals
CGE Partners has made a growth investment in Datapharm, the UK-based provider of regulatory-driven medicines information and software (including the electronic medicines compendium, emc). The investment will partner with Datapharm's management to accelerate new product development, international expansion, and support strategic acquisitions.
-
Walter Capital Partners Makes Minority Growth Investment in MEDFAR Clinical Solutions
February 16, 2021
Healthcare Services
Walter Capital Partners led a group of investors in a minority growth investment of close to $25 million in MEDFAR Clinical Solutions to support the EMR provider's expansion in Canada and the U.S. MEDFAR is a Montreal-based cloud-based SaaS EMR/Care Management Solution (MYLE) and will leverage the capital and Walter Capital's operational expertise to accelerate market growth.
-
DW Healthcare Partners Invests in Parnell Pharmaceuticals
February 1, 2021
Veterinary
DW Healthcare Partners completed an investment in Parnell Pharmaceuticals Holdings Ltd, a fully integrated animal-health pharmaceutical developer and sterile-injectable manufacturer, and took seats on the company's board. DWHP said the capital and board expansion will support Parnell's growth in the U.S. and expansion of its product portfolio and manufacturing capabilities in animal health.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.